2666-6022

American Heart Journal Plus Cardiology Research and Practice

Elsevier

View prefix report (10.1016)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 801 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact801 DOIs
2

Attach ORCID iDs across 753 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact753 DOIs
3

Deposit reference lists for 16 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact16 DOIs

DOIs for this ISSN

Showing the top 5 of 801 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Post-Acute COVID-19 Syndrome and the cardiovascular system:… (10.1016/j.ahjo.2021.100025)
Abstract ORCID
88.17 57
2 Sex and gender differences in COVID-19: More to be learned! (10.1016/j.ahjo.2021.100011)
Abstract ORCID
82.17 43
3 Representation of women in heart failure clinical trials: Ba… (10.1016/j.ahjo.2022.100093)
Abstract ORCID
80.64 40
4 Artificial intelligence and imaging: Opportunities in cardio… (10.1016/j.ahjo.2022.100126)
Abstract ORCID
77.82 35
5 Artificial intelligence opportunities in cardio-oncology: Ov… (10.1016/j.ahjo.2022.100129)
Abstract ORCID
76.57 33
6 Underrepresentation of women in cardiovascular trials- it is… (10.1016/j.ahjo.2022.100109)
Abstract ORCID
75.93 32
7 Team principles for successful interdisciplinary research te… (10.1016/j.ahjo.2023.100306)
Abstract ORCID
74.57 30
8 Sex differences in cardiovascular outcomes of SGLT-2 inhibit… (10.1016/j.ahjo.2023.100261)
Abstract ORCID
69.90 24
9 Assessing readability and comprehension of web-based patient… (10.1016/j.ahjo.2023.100308)
Abstract ORCID
69.90 24
10 Post-cardiac injury syndrome: An evidence-based approach to… (10.1016/j.ahjo.2021.100068)
Abstract ORCID
69.01 23
11 Chronic rheumatologic disorders and cardiovascular disease r… (10.1016/j.ahjo.2023.100267)
Abstract ORCID
67.12 21
12 Efficacy and safety of inclisiran a newly approved FDA drug:… (10.1016/j.ahjo.2022.100127)
Abstract ORCID
65.05 19
13 Sex differences in aortic stenosis: Identification of knowle… (10.1016/j.ahjo.2022.100197)
Abstract ORCID
65.05 19
14 Small-vessel disease in the brain (10.1016/j.ahjo.2023.100277)
Abstract ORCID
61.52 16
15 Peripheral arterial disease: A small and large vessel proble… (10.1016/j.ahjo.2023.100291)
Abstract ORCID
61.52 16
16 INOCA/ANOCA: Mechanisms and novel treatments (10.1016/j.ahjo.2023.100302)
Abstract ORCID
61.52 16
17 Establishing an interdisciplinary research team for cardio-o… (10.1016/j.ahjo.2022.100094)
Abstract ORCID
60.21 15
18 Cardiovascular disease in patients with metabolic dysfunctio… (10.1016/j.ahjo.2024.100386)
Abstract ORCID
60.21 15
19 Artificial intelligence: Applications in cardio-oncology and… (10.1016/j.ahjo.2024.100479)
Abstract ORCID
60.21 15
20 Differentiating EPA from EPA/DHA in cardiovascular risk redu… (10.1016/j.ahjo.2022.100148)
Abstract ORCID
58.80 14
21 Accelerated magnetocardiography in the evaluation of patient… (10.1016/j.ahjo.2024.100372)
Abstract ORCID
58.80 14
22 Myocarditis following mRNA vaccination against SARS-CoV-2, a… (10.1016/j.ahjo.2021.100042)
Abstract ORCID
57.31 13
23 The association between frailty and incident cardiovascular… (10.1016/j.ahjo.2023.100289)
Abstract ORCID
57.31 13
24 Estimated pulse wave velocity and incident heart failure and… (10.1016/j.ahjo.2022.100238)
Abstract ORCID
55.70 12
25 STEMI care 2021: Addressing the knowledge gaps (10.1016/j.ahjo.2021.100044)
Abstract ORCID
53.96 11
26 The evolution of “pillars of therapy” to reduce heart failur… (10.1016/j.ahjo.2022.100187)
Abstract ORCID
53.96 11
27 MINOCA: Myocardial infarction no obstructive coronary artery… (10.1016/j.ahjo.2023.100312)
Abstract ORCID
53.96 11
28 Novel insights into cardiovascular toxicity of cancer target… (10.1016/j.ahjo.2024.100374)
Abstract ORCID
53.96 11
29 Safety and effects of SGLT-2 inhibitor use among LVAD patien… (10.1016/j.ahjo.2022.100154)
Abstract ORCID
52.07 10
30 Lipoprotein(a): An important piece of the ASCVD risk factor… (10.1016/j.ahjo.2023.100350)
Abstract ORCID
52.07 10
31 Effect of aspirin on cholesterol crystallization: A potentia… (10.1016/j.ahjo.2021.100083)
Abstract ORCID
50.00 9
32 Characteristics of Takotsubo cardiomyopathy in patients with… (10.1016/j.ahjo.2022.100092)
Abstract ORCID
50.00 9
33 Enhanced external counterpulsation for management of symptom… (10.1016/j.ahjo.2022.100105)
Abstract ORCID
50.00 9
34 Portable air cleaner use and biomarkers of inflammation: A s… (10.1016/j.ahjo.2022.100182)
Abstract ORCID
50.00 9
35 Echocardiographic evaluation of the right atrial size and fu… (10.1016/j.ahjo.2023.100274)
Abstract ORCID
50.00 9
36 Underlying and contributing causes of mortality from CDC WON… (10.1016/j.ahjo.2025.100499)
Abstract ORCID
50.00 9
37 The diastolic blood pressure J-curve revisited: An update (10.1016/j.ahjo.2021.100065)
Abstract ORCID
47.71 8
38 Healthcare resource utilization and cost of obstructive hype… (10.1016/j.ahjo.2022.100089)
Abstract ORCID
47.71 8
39 Protection by inclusion: Increasing enrollment of women in c… (10.1016/j.ahjo.2022.100091)
Abstract ORCID
47.71 8
40 Effect of the COVID-19 pandemic on adversity in individuals… (10.1016/j.ahjo.2022.100096)
Abstract ORCID
47.71 8
41 Trends in pulmonary embolism mortality rates by age group in… (10.1016/j.ahjo.2022.100103)
Abstract ORCID
47.71 8
42 The pursuit of health equity in digital transformation, heal… (10.1016/j.ahjo.2022.100160)
Abstract ORCID
47.71 8
43 Characteristics of patients referred to a cardiovascular dis… (10.1016/j.ahjo.2022.100176)
Abstract ORCID
47.71 8
44 TEXT MY BP MEDS NOLA: A pilot study of text-messaging and so… (10.1016/j.ahjo.2023.100253)
Abstract ORCID
47.71 8
45 The current use of vasoactive agents in cardiogenic shock re… (10.1016/j.ahjo.2025.100524)
Abstract ORCID
47.71 8
46 The association between lipid levels and leukocyte count: A… (10.1016/j.ahjo.2021.100024)
Abstract ORCID
45.15 7
47 Impact of continuous positive airway pressure ventilation on… (10.1016/j.ahjo.2021.100056)
Abstract ORCID
45.15 7
48 Outcomes of Impella compared with intra-aortic balloon pump… (10.1016/j.ahjo.2021.100067)
Abstract ORCID
45.15 7
49 A prospective cohort study of the impact of outpatient Inten… (10.1016/j.ahjo.2022.100100)
Abstract ORCID
45.15 7
50 Utility of exercise testing to assess athletes for post COVI… (10.1016/j.ahjo.2022.100125)
Abstract ORCID
45.15 7